Mood disorders are associated with an increased risk of aging-related diseases, which greatly contribute to the excess morbidity and mortality observed in affected individuals. Clinical and molecular findings also suggest that mood disorders might be characterized by a permanent state of low-grade inflammation. At the cellular level, aging translates into telomeres shortening. Intriguingly, inflammation and telomere shortening show a bidirectional association: a pro-inflammatory state seems to contribute to aging and telomere dysfunction, and telomere attrition is able to induce low-grade inflammation. Several independent studies have reported shorter telomere length and increased levels of circulating inflammatory cytokines in mood disorders, suggesting a complex interplay between altered inflammatory⁻immune responses and telomere dynamics in the etiopathogenesis of these disorders. In this review, we critically discuss studies investigating the role of telomere attrition and inflammation in the pathogenesis and course of mood disorders, and in pharmacological treatments with psychotropic medications.

Mood Disorders, Accelerated Aging, and Inflammation: Is the Link Hidden in Telomeres?

Squassina, Alessio
Primo
Writing – Review & Editing
;
Pisanu, Claudia
Secondo
Writing – Original Draft Preparation
;
Vanni, Roberta
Ultimo
Supervision
2019-01-01

Abstract

Mood disorders are associated with an increased risk of aging-related diseases, which greatly contribute to the excess morbidity and mortality observed in affected individuals. Clinical and molecular findings also suggest that mood disorders might be characterized by a permanent state of low-grade inflammation. At the cellular level, aging translates into telomeres shortening. Intriguingly, inflammation and telomere shortening show a bidirectional association: a pro-inflammatory state seems to contribute to aging and telomere dysfunction, and telomere attrition is able to induce low-grade inflammation. Several independent studies have reported shorter telomere length and increased levels of circulating inflammatory cytokines in mood disorders, suggesting a complex interplay between altered inflammatory⁻immune responses and telomere dynamics in the etiopathogenesis of these disorders. In this review, we critically discuss studies investigating the role of telomere attrition and inflammation in the pathogenesis and course of mood disorders, and in pharmacological treatments with psychotropic medications.
2019
aging; antidepressants; bipolar disorder; inflammation; lithium; major depression; mood disorders; mood stabilizers; telomere shortening
File in questo prodotto:
File Dimensione Formato  
cells-08-00052 2019-01-15 07_17_56.pdf

accesso aperto

Tipologia: versione editoriale
Dimensione 433.21 kB
Formato Adobe PDF
433.21 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11584/259146
Citazioni
  • ???jsp.display-item.citation.pmc??? 13
  • Scopus 40
  • ???jsp.display-item.citation.isi??? 35
social impact